U.S. House · 118th Congress · H.R. 6275

Protecting Consumer Access to Generic Drugs Act of 2023

To prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes.

Sponsor

Marie Gluesenkamp PerezD-WA-3

Introduced

November 7, 2023, in the House

Issue areas

• Healthcare

Policy area

Health (from the Congressional Research Service)

Full text and actions

congress.gov